Journals / Türk Geriatri Dergisi / 2021 / Cilt: 24 - Sayı: 2

RETINAL NEURODEGENERATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE AN OPTICAL COHERENCE TOMOGRAPHY STUDY

Pages
185–195
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results showed that retinal axon loss might develop in Alzheimer’s disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Recent developments suggest that optical coherence tomography can play an important role in diagnosing and following-up neurodegenerative diseases, including Alzheimer’s disease.
📊
Key Findings & Data:Materials and Method: Seventy patients with amnestic type mild cognitive impairment, 54 patients with middle-stage Alzheimer’s disease, and 54 cognitively healthy individuals were included.
💡
Conclusion & Impact:Conclusion: The results showed that retinal axon loss might develop in Alzheimer’s disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Recent developments suggest that optical coherence tomography can play an important role in diagnosing and following-up neurodegenerative diseases, including Alzheimer’s disease. This study evaluates optical coherence tomography findings in mild cognitive impairment and middle-stage Alzheimer’s disease patients. Materials and Method: Seventy patients with amnestic type mild cognitive impairment, 54 patients with middle-stage Alzheimer’s disease, and 54 cognitively healthy individuals were included. All study participants were evaluated with neuropsychological tests, ophthalmological examination, and optical coherence tomography. Ganglion cell complex and retinal nerve fiber layer thicknesses were measured, and comparisons were made between groups. Results: Inferior temporal and inferior retinal nerve fiber layer thicknesses were thinner in the middle-stage Alzheimer’s disease group than in the control and mild cognitive impairment groups. After statistical corrections, the inferior and inferior temporal retinal nerve fiber layers were thinner in the middle- stage Alzheimer’s disease group compared to the control and mild cognitive impairment groups. Besides, the nasal and nasal lower retinal nerve fiber layers were thicker than the control group. No statistically significant difference was found between the groups in terms of mean, superior and inferior ganglion cell complex thickness. Conclusion: The results showed that retinal axon loss might develop in Alzheimer’s disease. This loss may be focal, and the inferior temporal region may have selective sensitivity. Optical coherence tomography might reflect the neuropathological process in Alzheimer’s disease, contribute to the diagnosis and follow-up. However, it is not helpful in the early diagnosis of Alzheimer’s disease because of the lack of difference between mild cognitive impairment and control groups.

🔖

Cite This Article

MUNİS, Ö. B., GÜVEN, H. H., ÇELİKAY, O., ÇOMOĞLU, S. S., ÖLÇÜCÜOĞLU, L. C. A., ERASLAN, N. (2022). RETINAL NEURODEGENERATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE AN OPTICAL COHERENCE TOMOGRAPHY STUDY. Türk Geriatri Dergisi, Cilt: 24 - Sayı: 2, 185–195. https://ajindex.com/articles/623550

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ong Y-L, Ong Y-T, Ikram MK, Chen CLH, Wong TY. Potential Applications of Spectral-Domain Opti- cal Coherence Tomography (SD-OCT) in the Study of Alzheimer’s Disease. Proceedings of Singapore Healthcare. 2014;23(1):74-83. (DOI:10.1177/2010105 81402300112)
  2. Moschos MM, Markopoulos I, Chatziralli I et al. Struc- tural and functional impairment of the retina and op- tic nerve in Alzheimer’s disease. Curr Alzheimer Res 2012;9: 782–788. (PMID: 22698074)
  3. Lee MJ, Abraham AG, Swenor BK et al. Applica- tion of optical coherence tomography in the detec- tion and classification of cognitive decline. J Curr Glaucoma Pract 2018 Jan-Apr;12(1):10-18. (PMID: 29861577)
  4. Grimaldi A, Brighi C, Peruzzi G et al. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer’s disease in the 3xTg-AD mouse model. Cell Death Dis 2018 Jun 7;9(6): 685. (PMID: 29880901)
  5. Hinton DR, Sadun AA, Blanks JC et al. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med 1986 Aug 21;315(8): 485-7. (PMID: 3736630)
  6. Ascaso FJ, Cruz N, Modrego PJ et al. Retinal alter- ations in mild cognitive impairment and Alzheimer’s disease: an optical coherence tomography study. J Neurol 2014 Aug;261(8): 1522-30. (PMID: 24846203)
  7. Garcia-Martin ES, Rojas B, Ramirez A et al. Macular thickness as a potential biomarker of mild Alzheim- er’s disease. Ophthalmology 2014 May;121(5): 1149- 1151.e3. (PMID: 24656417)
  8. Thomson KL, Yeo JM, Waddell B, Cameron JR, Pal S. A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography. Alzheimers Dement (Amst) 2015 Apr 23;1(2): 136-43. (PMID: 27239501)
  9. Ko F, Muthy ZA, Gallacher J et al. Association of ret- inal nerve fiber layer thinning with current and future cognitive decline: a study using optical coherence tomography. JAMA Neurol 2018 Jun 25. (PMID: 29946685)
  10. Mutlu U, Colijn JM, Ikram MA et al. Association of retinal neurodegeneration on optical coherence tomography with dementia: a population-based study. JAMA Neurol 2018 Jun 25. (PMID: 29946702)
  11. Cruz-Herranz A, Balk LJ, Oberwahrenbrock T et al. The APOSTEL recommendations for reporting quan- titative optical coherence tomography studies. Neu- rology 2016 Jun 14;86(24): 2303-9. (PMID: 27225223)
  12. Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer’s disease. Brain Res 1989;501(2): 364-372. (PMID: 2819446)
  13. Cheung CY, Ong YT, Hi